celastrol has been researched along with Bile Duct Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, W; He, J; Li, W; Liu, H; Meng, K; Pan, Y; Qiu, Y; Wang, L; Wang, T; Wang, Z; Xie, Y; Xu, G; Xu, L; Xu, X; Zhang, Y; Zhou, Y; Zhu, Y | 1 |
| Wei, Y; Zhu, B | 1 |
2 other study(ies) available for celastrol and Bile Duct Neoplasms
| Article | Year |
|---|---|
Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2-Mediated Unfolded Protein Reaction Activation.
Topics: Animals; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Copper; Endoplasmic Reticulum Chaperone BiP; Lipids; Mice | 2023 |
Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Prognosis; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Triterpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |